REFERENCES
- Davison SN. Am J Kidney Dis. 2003;42(6):1239–47.
- Perrone RD, Ruthazer R, Am J Kidney Dis. 2001;38(4):777–84.
- Grantham JJ. N Eng J Med. 2008;359(14):1477–85.
- Santoro D, Satta E, Clin Nephrol. 2013;79(Suppl 1):S2–S11.
- Milutinovic J, Fialkow PJ, Q J Med. 1984;53(212):511–22.
- Delaney VB, Adler S, Am J Kidney Dis. 1985;5(2):104–11.
- Pirson Y, Chauveau D, Autosomal-dominant polycystic renal disease. In Davison AM, Cameron JS, et al (editors). Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, 1998.
- Hogan MC, Norby SM. Adv Chronic Kidney Dis. 2010;17(3):e1–e16.
REFERENCES
- Delemarre FM, Schoenmakers CH. BJOG: Int J Obstet Gynaecol. 2008;115(9):1192.
- Salisbury EM, Game DS, Postgrad Med J. 2009;85(999):30–33.
- Barakzoy AS, Moss AH. J Am Soc Nephrol. 2006;17(11):3198–3203.
- Deray G. Presse Méd. 2004;33(7):483–9.
- Liukas A, Kuusniemi K, Clin Pharmacokinet. 2011;50(2):121–29.
REFERENCES
- King S, Forbes K, Palliat Med 2011;25(5):525–52.
- Mazzocato C, Beauverd M, Palliat Med 2006;20:301.
- Ferro CJ, Chambers EJ, Management of pain in renal failure. In: Chambers EJ, Germain M, et al. (editors.), Supportive Care for the Renal Patient. Oxford, Oxford University Press, 2004.
- Niscola P, Scaramucci L, Curr Drug Targets. 2010;11(6):752–58.